Amy Mulderry 

Interim President, CarelonRx

As interim leader of CarelonRx, Amy Mulderry is responsible for advancing the integrated, whole-person approach to care delivery for the pharmacy business, including pharmacy benefit management, specialty pharmacy, infusion, and pharmacy home delivery.

Prior to assuming leadership of CarelonRx, Amy was Senior Vice President and Chief Financial Officer for Carelon, as well as Chief Development Officer at Elevance Health. Her duties included leading inorganic growth strategy, which involved joint ventures and minority investments, mergers and acquisitions, and corporate integration.

Before joining Elevance Health, Amy spent twenty years as a healthcare industry investor managing equity portfolios at top-tier asset management firms. She served as Managing Partner and Portfolio Manager for Tavio Capital LLC, where she managed a $600 million long/short equity healthcare hedge fund as a sub-advisor to the Blackstone Equity Managed Account Platform, and a healthcare dedicated beta-neutral fund with a primary focus on healthcare services and medical device sectors. Amy also held previous healthcare portfolio management roles with Citadel Global Equities, SAC Capital, Salomon Brothers Asset Management, and CIBC World Markets Corp.

Follow us on LinkedIn  to learn how our leaders are solving today’s most complex health challenges.